Characterization and management of ERK inhibitor associated dermatologic adverse events: analysis from a nonrandomized trial of ulixertinib for advanced cancers

J. Wu, D. Liu, M. Offin, C. Lezcano, J. M. Torrisi, S. Brownstein, D. M. Hyman, M. M. Gounder, W. Abida, A. Drilon, J. J. Harding, R. J. Sullivan, F. Janku, D. Welsch, M. Varterasian, A. Groover, B. T. Li, M. E. Lacouture

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'Characterization and management of ERK inhibitor associated dermatologic adverse events: analysis from a nonrandomized trial of ulixertinib for advanced cancers'. Together they form a unique fingerprint.

Medicine & Life Sciences